Stock EQL EQL PHARMA AB
Add to a list
To use this feature you must be a member
Log inSign up

Company EQL Pharma AB

Equities

EQL

SE0005497732

Drug Retailers

Delayed Nasdaq Stockholm
Other stock markets
 02:52:19 16/07/2024 pm IST 		5-day change 1st Jan Change
57 SEK +0.71% Intraday chart for EQL Pharma AB -4.04% +70.66%

Business Summary

EQL Pharma AB is a Sweden-based Company that operates as a generic drugs and specialty pharmaceutical company. The Company engages in marketing, distributing, and selling generic drugs and specialty pharmaceuticals. Its main products are Anastrozol, Venlafaxin, Carvedilol, Metformin, Sumatriptan, Mometason, Glepark, among others. The company operates in Sweden and in Scandinavia.

Number of employees: 21

Sales per Business

SEK in Million2023Weight2024Weight Delta
Medicines
100.0 %
- - 264 100.0 % -

Sales per region

SEK in Million2023Weight2024Weight Delta
Sweden
55.0 %
163 62.6 % 145 55.0 % -10.74%
Denmark
21.7 %
-- 57 21.7 % -
Rest of Europe
10.7 %
23 8.9 % 28 10.7 % +22.47%
Norway
10.0 %
-- 27 10.0 % -
Finland
2.6 %
-- 7 2.6 % -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 29,063,610 29,063,610 ( 100.00 %) 0 100.00 %

Shareholders

NameEquities%Valuation
Rajiv Indravadan Modi
30.00 %
8,718,500 30.00 % 42 M kr
Lars Christer Fedrik Fåhraeus
29.00 %
8,427,348 29.00 % 41 M kr
SEB Investment Management AB
2.190 %
636,493 2.190 % 3 M kr
Sten Irwe
1.540 %
447,579 1.540 % 2 M kr
Carnegie Fonder AB
1.515 %
440,258 1.515 % 2 M kr
Emanuel Eriksson
1.100 %
319,699 1.100 % 2 M kr
Axel Schörling
1.070 %
311,016 1.070 % 1 M kr
Cliens Kapitalförvaltning AB
1.056 %
306,928 1.056 % 1 M kr
Petersen Martin Sokjer
1.030 %
299,355 1.030 % 1 M kr
Alexander Brising
0.8827 %
256,543 0.8827 % 1 M kr

Company contact information

EQL Pharma AB

Stortorget 1

222 23, Lund

+46 46 12 01 70

http://www.eqlpharma.com
address EQL Pharma AB(EQL)

Sector

Consumer Non-Cyclicals
Food & Drug Retailing
Food & Drug Retailing
Drug Retailers
Other Drug Retailers

Sales per Business

Sales per region

Ratings for EQL Pharma AB

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Drug Retailers

1st Jan change Capi.
EQL PHARMA AB Stock EQL Pharma AB
+70.66% 155M
WALGREENS BOOTS ALLIANCE, INC. Stock Walgreens Boots Alliance, Inc.
-55.19% 10.1B
JD HEALTH INTERNATIONAL INC. Stock JD Health International Inc.
-46.55% 8.81B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED Stock Alibaba Health Information Technology Limited
-25.71% 6.65B
MATSUKIYOCOCOKARA & CO. Stock MatsukiyoCocokara & Co.
-4.16% 6.45B
CORPORATIVO FRAGUA, S.A.B. DE C.V. Stock Corporativo Fragua, S.A.B. de C.V.
+97.00% 5.35B
NAHDI MEDICAL COMPANY Stock Nahdi Medical Company
-2.77% 4.63B
CLICKS GROUP LIMITED Stock Clicks Group Limited
+8.08% 4.6B
YIFENG PHARMACY CHAIN CO., LTD. Stock Yifeng Pharmacy Chain Co., Ltd.
-32.12% 3.79B
REDCARE PHARMACY NV Stock Redcare Pharmacy NV
+6.91% 3.13B
Other Drug Retailers
  1. Stock Market
  2. Equities
  3. EQL Stock
  4. Company EQL Pharma AB